Developing an Intervention to Address Suicide Risk During Substance Use Disorder
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01127932|
Recruitment Status : Completed
First Posted : May 21, 2010
Last Update Posted : May 13, 2015
|Condition or disease||Intervention/treatment|
|Suicide Substance-Related Disorders||Behavioral: Psychoeducation for substance abuse Behavioral: CBT for suicide in Substance abuse|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||56 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Participant, Investigator)|
|Primary Purpose:||Supportive Care|
|Study Start Date :||April 2010|
|Primary Completion Date :||July 2011|
|Study Completion Date :||September 2011|
|Experimental: CBT for suicide||
Behavioral: CBT for suicide in Substance abuse
The therapeutic intervention group is designed to provide beneficial coping strategies that are helpful in dealing with both substance use and suicidal thoughts.
Active Comparator: Enhanced care control group
This group is designed to be an active control which provides detailed information about substance use, suicide risk, and depression without providing any CBT or other specific therapy.
Behavioral: Psychoeducation for substance abuse
This active control provides detailed information about substance use, suicide risk, and depression to those enrolled.
- Level of Suicidal Ideation [ Time Frame: Six months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01127932
|United States, Michigan|
|Community Programs, INC.|
|Waterford, Michigan, United States, 48327|